MedPath

Safety and Efficacy of the CarboFix Pedicle Screw System

Not Applicable
Completed
Conditions
Degenerative Disc Disease
Spinal Curvatures
Spondylolisthesis
Spinal Stenosis
Tumor
Interventions
Device: Pedicle screw system
Registration Number
NCT02039232
Lead Sponsor
CarboFix Orthopedics Ltd.
Brief Summary

The purpose of this study is to evaluate the safety and efficacy of CarboFix' Pedicle Screw System in the lumbar spine.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
46
Inclusion Criteria
  1. Subject is 18 years old or older.
  2. Confirmation that the physical examination of radiopathy, myelopathy or combination is in correlation with the affected level.
  3. Lumbar CT, MRI, or myelography confirms the level of involvement is consistent with the subject's examination.
  4. Informed consent given by the subject.
Exclusion Criteria
  1. Subject is not eligible for fixation with market-available fixation means.

  2. Familial history NF2.

  3. Acute traumatic spinal injury with or without neurological signs.

  4. Metabolic bone disease.

  5. History of Paget's disease or other osteodystrophies whether acquired or congenital, including renal osteodystrophy, hyperthyroidism, hypothyroidism hyperparathyroidism, Ehrlers-Danlos-syndrome, osteogenesis imperfecta, achondroplasia, tuberculosis.

  6. History of mental disorder or current psychiatric treatment.

  7. Pregnancy and/or female subjects intending to become pregnant within the expected time frame of the study and/or female subjects of child bearing age who do not use conventional contraceptive methods.

  8. Immune deficiency disease.

  9. Infection in the location of the operative site, discitis, osteomyelitis, fever and/or leukocytosis (as diagnosed based on the results of CBC and ESR tests).

  10. Scoliosis.

  11. Treatment with drugs that may interfere with bone metabolism such as:

    1. Cumulative dose of 150 mg. of Prednisone or equivalent within the last 6 months.
    2. Calcitonin within the past 6 months.
    3. Bisphosphonates for 30 days or more within the last 12 months.
    4. Bone therapeutic doses of fluoride for 30 days or more within the last 12 months.
    5. Bone therapeutic doses of vitamin D or Vitamin D metabolites for 30 days or more within the last 6 months.
    6. Treatment by chemotherapy within the last 12 months.
  12. Lack of willingness to make a commitment to return for required follow up visits.

  13. Drug and/or alcohol abuse.

  14. Morbid obesity.

  15. Metal allergies.

  16. Recent use of other investigational drugs or devices (within the past 30 days).

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
CarboFix Pedicle Screw SystemPedicle screw system-
Primary Outcome Measures
NameTimeMethod
Fusion success6 months post-operation
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (2)

Hillel Yafe MC;

šŸ‡®šŸ‡±

Hadera;, Israel

Herzliya Medical Center

šŸ‡®šŸ‡±

Herzliya, Israel

Ā© Copyright 2025. All Rights Reserved by MedPath